Nevro Corp.

NYSE: NVRO
Share price (3/28/25): $5.84
Market cap (3/28/25): $221 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Registration of securities for employees

Ownership Filter

Gamco Investors, Inc. Et Al

Christoforou Christofer

MacLeod Roderick H.

News Filter

Reports Fourth-Quarter and Full-Year 2024 Financial Results

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results

Reports Third-Quarter 2024 Financial Results Reaffirms Full-Year 2024 Revenue Guidance and Raises Full-Year 2024 Adjusted EBITDA Guidance

Reports Second-Quarter 2024 Financial Results Initiates Process Aimed at Accelerating Growth, Diversifying Product Portfolio and Maximizing Stockholder Value

Proxies Filter

Additional info about upcoming vote

Proxy related to merger

Preliminary proxy related to merger

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Conflict Minerals disclosure

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Conflict Minerals disclosure